US pharma major Eli Lilly on Thursday launched the muchawaited diabetes and obesity management drug Mounjaro (tirzepatide) in ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Eli Lilly introduced Mounjaro, a diabetes and weight-loss drug, in India, aiming to tackle obesity and diabetes. With a ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a ...

Eli Lilly has launched its blockbuster weight loss drug, Mounjaro, in India, offering a novel treatment for obesity and type ...

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s ...

Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both diabetes ...

The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...